RSS Feeds
Search

Articles

Pharmalicensing brings you advice, commentary and analysis from industry experts.

Articles

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Eli Lilly Drops Plans to Seek Approval For its Established Drug Alimta as a Treatment For Head And Neck Cancer
Nov 2010 - 5 pages - $500
Head and Neck Cancer - Pipeline Assessment and Market Forecast to 2017
Oct 2010 - 64 pages - $2,000
Cancer Biomarkers: Players, products and prospects (Volume I)
Aug 2008 - 138 pages - $1,040
Cancer, CNS & Cardiovascular Biomarkers: Players, products and prospects
Aug 2008 - 352 pages - $2,615
Innovations in Oncology Diagnostics
Oct 2009 - 141 pages - $3,835
Clinical Trial Endpoints in Oncology - Inclusion of Surrogate Endpoints and Shorter Endpoints Will Ensure Faster Clinical Trials in Oncology
Mar 2011 - 120 pages - $3,500
Advancing Molecular Diagnostics to Personalize Cancer Therapy
Jun 2011 - 187 pages - $3,835
Biomarkers: A Market Briefing
Jan 2007 - 90 pages - $1,995
Case Study: Personalized Cancer Therapy - The era of biomarker identification and companion diagnostic co-development
Mar 2011 - 50 pages - $1,900
Prostate Cancer Drug Discoveries: What the Future Holds
Nov 2009 - 160 pages - $2,265
More Related Market Research Reports >>>

Your selection

Industry sector
Diagnostic del
Biomarker-based diagnostics del
Therapeutic target
Oncology del
Head and neck cancer del
Paranasal sinus cancer del
Year
2010 del

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us